<h4>Objective</h4>To investigate the knowledge, attitudes, and practices (KAP) concerning osteoporosis among hormone receptor-positive (HR+) breast cancer patients.<h4>Methods</h4>A cross-sectional study was conducted from November, 2023, to March, 2024 among HR+ breast cancer patients to assess their KAP regarding osteoporosis. This evidence concerns the gene NR4A1 and breast carcinoma.